Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 2009

View Archived Issues

CSIR claims the discovery of novel anticancer agents

Novel PAPR inhibitors for the treatment of cancer described by Italian scientists

Positive modulators of nAChR in early development at NeuroSearch

Lundbeck discloses novel MCH-R1 ligands as antidepressants

Novartis presents novel PI3K inhibitors for the treatment of asthma

CDX-011 shows promising efficacy in advanced breast cancer patients

SS-1020, a new anti-estrogen candidate for treatment and prevention of breast cancer

AZD-1152 displays safety and efficacy in AML phase I/II trial

Unigene selects obesity drug UGP-281 as lead compound for development

Novel enzyme replacement therapy for Fabry disease in preclinical development

Fusion protein ACE-435 shows promise in cancer-induced cachexia therapy

UCB reports initial results for certolizumab pegol in Crohn's disease

BioDelivery Sciences presents phase II pain trial results for BEMA buprenorphine

Dual orexin receptor antagonist almorexant meets primary phase III endpoint

Vernakalant meets primary endpoint in European comparator study

Taro commences clinical trials with T-2007

Flamel initiates phase IIa IFN-alpha-2b XL trial in patients with chronic HCV

Ista submits supplemental NDA to FDA for once-daily XiDay

ChemoCentryx initiates phase II CCX-354 trial in rheumatoid arthritis

European CHMP recommends marketing authorization of Amgen's Prolia for osteoporosis

Ambit and Astellas to jointly develop and commercialize FLT3 kinase inhibitors

European CHMP recommends approval of Cangene's MAA for ImmunoGam

Cardium reports results from 10-year follow-up study of diabetic patients with foot ulcer

Myriad Pharmaceuticals to acquire Javelin Pharmaceuticals, including Dyloject

Seattle Genetics and GSK sign agreement for antibody-drug conjugate technology

Medicago reports phase I results for its avian flu pandemic vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...